Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis | PNAS
Pyk2 can functionally compensate for loss of FAK during angiogenesis.... | Download Scientific Diagram
FFSS reduces FAK activity, and FAK inhibitors mimic effect of FFSS a... | Download Scientific Diagram
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis | PNAS
FAK Is Required for TGFβ-induced JNK Phosphorylation in Fibroblasts: Implications for Acquisition of a Matrix-remodeling Phenotype | Molecular Biology of the Cell
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy | eLife
Pre-made Human PTK2 (FAK) knockout HEK-293T cell line (ab255421) | Abcam
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis | PNAS
TGF-β1 and FAK Regulate Periostin Expression in PDL Fibroblasts - W. Wen, E. Chau, L. Jackson-Boeters, C. Elliott, T.D. Daley, D.W. Hamilton, 2010
FAK Polyclonal Antibody (PA5-17591)
FAK Polyclonal Antibody (AHO0502)
![FAK Antibody [Unconjugated] (AF4467): Novus Biologicals](https://images.novusbio.com/images2/FAK_AF4467_Western_Blot_5471.jpg "FAK Antibody [Unconjugated] (AF4467): Novus Biologicals")
FAK Antibody [Unconjugated] (AF4467): Novus Biologicals
Pre-made Human PTK2 (FAK) knockout HEK-293T cell line (ab255421) | Abcam
Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth | Nature Communications
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy | eLife
Human FAK Antibody MAB4467: R&D Systems
FAK Monoclonal Antibody (34Q36) (AHO1272)
IJMS | Free Full-Text | FAK Family Kinases in Vascular Diseases
Human/Mouse/Rat FAK Antibody AF4467: R&D Systems
IJMS | Free Full-Text | FAK in Cancer: From Mechanisms to Therapeutic Strategies
